The pharmacokinetics and tissue penetration of ceftiaxone after a single intravenous injection of 1,000 mg to 17 patients for antibiotic prophylaxis in thoracic surgery were studied. The patients were scheduled for elective noncardiac thoracic surgery. Adequate levels in serum (higher than Noncardiac thoracic surgery is "contaminated-aseptic surgery" in most cases (4, 6, 7, 11) . Antibiotic prophylaxis is used against pathogens most likely to contaminate the surgical wound: Escherichia coli, various members of the family Enterobacteriaceae, Streptococcus spp., Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas spp. (4, 6, 7, 11 Ceftriaxone concentrations were determined by high-performance liquid chromatography (HPLC) (19) , with a normal-phase technique and an NH-bonded-phase column (Spherisorb C18 Waters; 100 mm; 5-pm internal diameter).
Noncardiac thoracic surgery is "contaminated-aseptic surgery" in most cases (4, 6, 7, 11) . Antibiotic prophylaxis is used against pathogens most likely to contaminate the surgical wound: Escherichia coli, various members of the family Enterobacteriaceae, Streptococcus spp., Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas spp. (4, 6, 7, 11) . Bacterial contamination may occur on parietal tissues, in the pleural cavity, or in lung tissues. It seems clear that for surgical prophylaxis, adequate antibiotic concentrations in tissues should be achieved in all the potential sites of infection (1) . In tissues with a tendency for postoperative infection, antibiotic activity should be maintained throughout the procedures, from incision to closure. For practical reasons, an ideal antibiotic prophylactic regimen should be as easy to administer as possible; single-dose administration is recommended in many types of surgery (5) .
This study was designed to determine whether a single dose of ceftriaxone can result in adequate concentrations being achieved and maintained in thoracic wall fat and lung tissue.
MATERIALS AND METHODS
This study received (Merck Laboratories), hexadecyl-trimethylammonium bromide (0.4g) (Fluka Laboratories), buffer (pH 7.0) (titrisol) (5 ml) (Merck), and HPLC-grade water (45 ml). The internal standard was Probenecid (Theraplix Laboratories). The bonded-phase column was connected to a UV spectrophotometer detector (254 nm).
For the determination of tissue ceftriaxone concentrations, tissue pretreatment was necessary. An aliquot of tissue (100 mg) was crushed in 1 ml of isotonic saline solution and centrifuged, and the ceftriaxone assay was performed on the supernatant. To 0.1 ml of the sample, 0.3 ml of water was added, and the mixture was vortexed. Two microliters of internal standard (200 ,ug/ml) in methanol was added, and the mixture was vigorously vortexed for 5 min. The mixture was centrifuged, and 25 pl of the supernatant was injected into the HPLC column. The formula of Roncoroni et al. was used to subtract, for the tissues, any blood contamination (17 is blood concentration in the tissue, C2 is blood ceftriaxone concentration, C3 is experimental tissue ceftriaxone concentration, C4 iS true tissue ceftriaxone concentration, F is the dilution factor for the tissue in normal saline, and Hb is hemoglobin.
The lower limits of detection were 0.5 p.g/ml for plasma samples and 0.5 ,ug/g for tissue samples, and the percent recovery with ceftriaxone was 98% ± 5%. Within-day and between-day reproducibilities were assayed over a concentration range of 1 to 400 p,g/liter, with coefficients of variation of 3 and 6%, respectively. Previous studies have established the basic principles of antibiotic prophylaxis in surgical procedures, and the main points are that (i) the antibiotic must be present in the involved tissues before surgery allows bacterial contamination and (ii) the drug must attain and maintain concentrations in serum and tissue high enough to inhibit the growth of contaminating pathogens (8, 18) .
In the present study, ceftriaxone concentrations in serum and thoracic tissues were compared with the MIC90s for E. No major modification in ceftriaxone pharmacokinetics in the study patients was seen. Results were similar to those reported for healthy volunteers, and in view of the present study, the single dose used (1,000 mg intravenously) can be recommended (14, 16) . This type of administration is easy and convenient.
The emergence of antimicrobial agent-resistant bacteria related to the use of prophylactic ceftriaxone could be reason for concern. Data suggest that prolonged (>48 h) postoperative prophylaxis is responsible for a modification of susceptibility to antimicrobial agents (3), but no deleterious effect of an appropriate short-course prophylactic regimen has been reported. Such data should preclude the use of multiple-dose antibiotic regimens, and continuous effort should be made to use short-course or single-dose prophylaxis whenever possible.
In conclusion, when a single dose of 1,000 mg of ceftriaxone is given before noncardiac thoracic surgery, adequate levels in serum and tissue can be achieved throughout the surgical procedures. The reasons for this result could be a long plasma elimination half-life and an excellent penetration into lipidic tissue.
